← Back to Search

New-Onset Diabetes Mellitus for Pancreatic Cancer (PANDOME Trial)

N/A
Recruiting
Led By Richard Frank, MD
Research Sponsored by Nuvance Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 3 years
Awards & highlights

Summary

The main goal of this study is to explore the relationship between new-onset diabetes mellitus/deteriorating diabetes and a subsequent diagnosis of pancreatic cancer. Magnetic Resonance Imaging and Magnetic cholangiopancreatography (MRI/MRCP) will be utilized to screen for early stage pancreatic cancer or precursor lesions. Participants will be asked to donate a blood sample at specific intervals for the creation of a bio-bank necessary for the development of a blood based screening test for pancreatic cancer.

Eligible Conditions
  • Pancreatic Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Early Stage Pancreatic Cancer or Precursor Lesions
Secondary outcome measures
Relative Risk of Pancreatic Cancer Among Individuals with Detiorating diabetes
Relative Risk of Pancreatic Cancer Among Individuals with New-Onset Diabetes

Trial Design

2Treatment groups
Experimental Treatment
Group I: New-Onset Diabetes MellitusExperimental Treatment1 Intervention
Diabetes Mellitus diagnosed within the past 12 months
Group II: Deteriorating Diabetes MellitusExperimental Treatment1 Intervention
History of Diabetes Mellitus with recent deteriorating within the past 6 months confirmed with repeat testing and not associated with weight gain or diabetes medication non-compliance

Find a Location

Who is running the clinical trial?

Yale UniversityOTHER
1,907 Previous Clinical Trials
3,018,249 Total Patients Enrolled
Nuvance HealthLead Sponsor
3 Previous Clinical Trials
400 Total Patients Enrolled
Richard Frank, MD4.529 ReviewsPrincipal Investigator - Nuvance Health
Nuvance Health
2 Previous Clinical Trials
400 Total Patients Enrolled
5Patient Review
I was already a big fan of Dr. Richard Frank before I even met him, thanks to his excellent book on cancer. He's extremely knowledgeable and has always been very approachable, which makes me feel safe. I'm grateful to have found such a treasure in my own backyard.
~267 spots leftby Jan 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top